OTCMKTS:INVVY - INDIVIOR PLC/S Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $7.25 +0.25 (+3.57 %) (As of 02/17/2019 04:00 PM ET)Previous Close$7.25Today's Range$7.06 - $7.4952-Week Range$4.73 - $33.83Volume1,589 shsAverage Volume4,506 shsMarket Capitalization$1.06 billionP/E Ratio4.03Dividend YieldN/ABeta0.34 ProfileDiscussionAnalyst RatingsChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, overdose rescue, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in Richmond, Virginia. Receive INVVY News and Ratings via Email Sign-up to receive the latest news and ratings for INVVY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Tobacco products Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:INVVY Previous SymbolNASDAQ:INVVY CUSIPN/A Webwww.indivior.com Phone44-17-5321-7800Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio4.03 Forward P/E Ratio4.03 P/E GrowthN/A Sales & Book Value Annual Sales$1.09 billion Price / Sales0.97 Cash Flow$1.9385 per share Price / Cash Flow3.74 Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)$1.80 Net Income$58 million Net Margins10.36% Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares145,660,000Market Cap$1.06 billion OptionableNot Optionable INDIVIOR PLC/S (OTCMKTS:INVVY) Frequently Asked Questions What is INDIVIOR PLC/S's stock symbol? INDIVIOR PLC/S trades on the OTCMKTS under the ticker symbol "INVVY." How were INDIVIOR PLC/S's earnings last quarter? INDIVIOR PLC/S (OTCMKTS:INVVY) announced its quarterly earnings results on Thursday, February, 14th. The company reported $0.45 EPS for the quarter. The company earned $236 million during the quarter. View INDIVIOR PLC/S's Earnings History. When is INDIVIOR PLC/S's next earnings date? INDIVIOR PLC/S is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for INDIVIOR PLC/S. What is the consensus analysts' recommendation for INDIVIOR PLC/S? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for INDIVIOR PLC/S in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for INDIVIOR PLC/S. Has INDIVIOR PLC/S been receiving favorable news coverage? News coverage about INVVY stock has been trending somewhat positive recently, InfoTrie reports. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. INDIVIOR PLC/S earned a news sentiment score of 1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. Who are some of INDIVIOR PLC/S's key competitors? Some companies that are related to INDIVIOR PLC/S include Turning Point Brands (TPB), Pharming Group (PHGUF), Standard Diversified Inc Class A (NYSEAMERICAN) (SDI), ADOCIA/S (ADOCY), Gilla (GLLA), Healthier Choices Management (HCMC) and Special Diversified Opportunities (SDOIA). Who are INDIVIOR PLC/S's key executives? INDIVIOR PLC/S's management team includes the folowing people: Mr. Shaun Thaxter, CEO & Exec. DirectorMr. Mark Crossley, CFO & Exec. DirectorDr. Christian Heidbreder, Chief Scientific OfficerMr. Ingo Elfering, Chief Information & Innovation OfficerMr. Jason Thompson, VP of Investor Relations How do I buy shares of INDIVIOR PLC/S? Shares of INVVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is INDIVIOR PLC/S's stock price today? One share of INVVY stock can currently be purchased for approximately $7.25. How big of a company is INDIVIOR PLC/S? INDIVIOR PLC/S has a market capitalization of $1.06 billion and generates $1.09 billion in revenue each year. The company earns $58 million in net income (profit) each year or $1.80 on an earnings per share basis. What is INDIVIOR PLC/S's official website? The official website for INDIVIOR PLC/S is http://www.indivior.com. How can I contact INDIVIOR PLC/S? INDIVIOR PLC/S's mailing address is 103-105 Bath Road, Slough X0, SL1 3UH. The company can be reached via phone at 44-17-5321-7800 or via email at [email protected] MarketBeat Community Rating for INDIVIOR PLC/S (OTCMKTS INVVY)Community Ranking: 1.9 out of 5 ()Outperform Votes: 74 (Vote Outperform)Underperform Votes: 119 (Vote Underperform)Total Votes: 193MarketBeat's community ratings are surveys of what our community members think about INDIVIOR PLC/S and other stocks. Vote "Outperform" if you believe INVVY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INVVY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/17/2019 by MarketBeat.com StaffFeatured Article: What is Cost of Debt?